MEJLGAARD INVEST ApS: Financial statements 2018
CVR: 10042933
Source: annual report 2018, Danish Business Authority
01/05/2017 – 30/04/2018
MEJLGAARD INVEST ApS (CVR 10042933) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -41,978 and a net result of DKK 390,673 compared with DKK -454,911 the year before. Equity in the 2018 report amounted to DKK 10,581,015. The solvency ratio was 76.2%.
- Gross Profit
- DKK -41,978
- Profit/Loss
- DKK 390,673
- Equity
- DKK 10,581,015
- Total Assets
- DKK 13,878,534
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -42K | 391K | 10.6M | 0 |
| 2017 | - | -44K | -455K | 10.3M | 1 |
| 2016 | - | -38K | -298K | 10.8M | - |
| 2015 | - | -26K | 1.9M | 11.2M | 0 |
| 2014 | - | -26K | 257K | 9.4M | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout MEJLGAARD INVEST ApS
MEJLGAARD INVEST ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 1985. The company has been dissolved on 3 September 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company was previously named S.M.J. PHARMA AF 1/10 85 ApS. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -35,584 and a net result of DKK 99,498 compared with DKK -493,634 the year before. Equity in the 2023 report amounted to DKK 16,267,957.